Milestone Pharmaceuticals Future Growth
Future criteria checks 0/6
Milestone Pharmaceuticals is forecast to grow earnings and revenue by 52.7% and 57.2% per annum respectively while EPS is expected to grow by 50.9% per annum.
Key information
52.7%
Earnings growth rate
50.9%
EPS growth rate
| Pharmaceuticals earnings growth | 22.8% |
| Revenue growth rate | 57.2% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 28 Mar 2024 |
Recent future growth updates
Recent updates
Is Milestone Pharmaceuticals (NASDAQ:MIST) A Risky Investment?
Sep 13
We're Keeping An Eye On Milestone Pharmaceuticals' (NASDAQ:MIST) Cash Burn Rate
Mar 07We're Keeping An Eye On Milestone Pharmaceuticals' (NASDAQ:MIST) Cash Burn Rate
Oct 15We Think Milestone Pharmaceuticals (NASDAQ:MIST) Can Afford To Drive Business Growth
Jun 24We're Hopeful That Milestone Pharmaceuticals (NASDAQ:MIST) Will Use Its Cash Wisely
Feb 25We're Interested To See How Milestone Pharmaceuticals (NASDAQ:MIST) Uses Its Cash Hoard To Grow
Aug 25Companies Like Milestone Pharmaceuticals (NASDAQ:MIST) Are In A Position To Invest In Growth
Apr 02What You Need To Know About Milestone Pharmaceuticals Inc.'s (NASDAQ:MIST) Investor Composition
Jan 15First patient enrolled in Milestone Pharmaceuticals' late-stage study of etripamil in PSVT
Nov 18Milestone Pharmaceuticals EPS beats by $0.09
Nov 13Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 88 | -17 | 41 | 56 | 2 |
| 12/31/2025 | 13 | -83 | -46 | -36 | 4 |
| 12/31/2024 | N/A | -60 | -50 | -45 | 4 |
| 12/31/2023 | 1 | -60 | -47 | -46 | N/A |
| 9/30/2023 | 5 | -59 | -50 | -49 | N/A |
| 6/30/2023 | 6 | -59 | -49 | -49 | N/A |
| 3/31/2023 | 6 | -59 | -53 | -52 | N/A |
| 12/31/2022 | 5 | -58 | -53 | -52 | N/A |
| 9/30/2022 | 2 | -62 | -52 | -52 | N/A |
| 6/30/2022 | N/A | -62 | -50 | -50 | N/A |
| 3/31/2022 | 15 | -44 | -35 | -35 | N/A |
| 12/31/2021 | 15 | -43 | -33 | -33 | N/A |
| 9/30/2021 | 15 | -35 | -30 | -30 | N/A |
| 6/30/2021 | 15 | -32 | -28 | -28 | N/A |
| 3/31/2021 | N/A | -46 | -45 | -45 | N/A |
| 12/31/2020 | N/A | -50 | -51 | -51 | N/A |
| 9/30/2020 | N/A | -60 | -59 | -59 | N/A |
| 6/30/2020 | N/A | -60 | -60 | -60 | N/A |
| 3/31/2020 | N/A | -61 | -55 | -54 | N/A |
| 12/31/2019 | N/A | -55 | -52 | -51 | N/A |
| 9/30/2019 | N/A | -47 | -42 | -42 | N/A |
| 6/30/2019 | N/A | -40 | -39 | -39 | N/A |
| 3/31/2019 | N/A | -29 | -31 | -31 | N/A |
| 12/31/2018 | N/A | -23 | -21 | -21 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: MIST is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: MIST is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: MIST is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: MIST is forecast to have no revenue next year.
High Growth Revenue: MIST is forecast to have no revenue next year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if MIST's Return on Equity is forecast to be high in 3 years time